Correction: Genomic Deletion of Chromosome 12p Is an Independent Prognostic Marker in Prostate Cancer

Oncotarget - United States
doi 10.18632/oncotarget.14557
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Ribosomal Protein L19 Is a Prognostic Marker for Human Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

NADiA ProsVue Prostate-Specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy

Urology
Urology
2012English

Prostate Cancer Genomic Signature Offers Prognostic Value

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

CD24 Is Expressed in Ovarian Cancer and Is a New Independent Prognostic Marker of Patient Survival

American Journal of Pathology
Forensic MedicinePathology
2002English

Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer

PLoS ONE
Multidisciplinary
2016English

Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients

Contrast Media and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2018English

Maximum Tumor Diameter Is an Independent Predictor of Prostate-Specific Antigen Recurrence in Prostate Cancer

Modern Pathology
Forensic MedicinePathology
2005English

miR‑320a Is an Independent Prognostic Biomarker for Invasive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy